Applied Biosystems
This article was originally published in The Gray Sheet
Executive Summary
Reduction in force of 9%, including about 400 regular staff and 100 contract and temporary positions, will result in a charge of about $40 mil. in the second quarter. The RIFs affect all function areas, including R&D, primarily in the U.S. and Europe. The cuts "should enable us to better manage through an uncertain environment while maintaining our focus on leading-edge research," explains President Michael Hunkapiller...